Korea Investment Partners
Korea Investment Partners
Leading venture capital and private equity firm driving global innovation across diverse technology sectors.
About
Korea Investment Partners (KIP) is a subsidiary of Korea Investment Holdings (KIH), one of the largest private financial groups in Korea, and working as venture capital & private equity arm of KIH. Through 37 years of experience in investment field, KIP is currently managing 58 funds with AUM of US$4 billion. Since 2001, KIP has liquidated 18 funds with average multiple of 2.0x and IRR of 16.7%.
Key facts
- Website
- kipvc.com
- Type
- Venture Capital
- Headquarters
- Seoul, South Korea
- Funds raised
- $350M
- Portfolio companies
- 13
- Stages
- Series ASeries CSeries E
- Cheque size
- $5M to $100M
- Sector focus
- FintechTradingSocialE-CommerceSearch
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 20 Nov 2024 | BreezeBio | Series B | $35M |
| 6 Nov 2024 | Kardome | Series A | $10M |
| 19 Mar 2024 | NeuReality | Series A2 | $20M |
| 23 Jan 2024 | BreezeBio | Series A1 | $24M |
| 20 Oct 2023 | Uplandme | Series A | $7M |
| 31 Jul 2023 | eToro | Secondary Transaction | $120M |
| 1 May 2023 | AIRS Medical | Series A | $15M |
| 18 Apr 2023 | TwelveLabs | Undisclosed round | $13M |
| 22 Mar 2023 | 431010 | Advanced Investment Agreement (AIA) | $250M |
| 8 Mar 2023 | Kardome | Funding Round | $1M |
Add first review
Frequently asked
What companies has Korea Investment Partners invested in?
Korea Investment Partners has invested in BreezeBio, Kardome, NeuReality, Uplandme, eToro and 8 more.
AUM
$350M
PORTFOLIO
13